Skip to content

Prophylactic use of extracorporeal membrane oxygenation (ECMO) in the intervention of complex and high-risk coronary artery disease

Prophylactic use of extracorporeal membrane oxygenation (ECMO) in the intervention of complex and high-risk coronary artery disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046630
Enrollment
Unknown
Registered
2021-05-23
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Group 2:Extracorporeal membrane oxygenation(ECMO)

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unstable/stable angina who were included in elective PCI, 18-85 years old, refused surgical CABG; 2. All patients have Syntax points >= 33 and Euroscore >= 6 points; 3. EF35%, and one of the following standards is combined at the same time: (1) Coronary artery calcification requires rotational atherectomy, (2) Unprotected left main disease, (3) Severe three-vessel coronary artery disease (at least 1 or more CTO combined with other coronary artery stenosis > 70%). 5. All patients must meet criteria 1 and 2, and meet any one of criteria 3 or 4 to be included.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction; 2. Cardiogenic shock; 3. Anemia (Hb < 90g/L); 4. Platelets < 100 x 10^9/L; 5. Stroke (hemorrhagic or ischemic) occurred in the past six months; 6. Patients with tumors; 7. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiac and cerebrovascular events during hospitalization, during PCI and within 1 month after discharge (including all-cause death, acute myocardial infarction, revascularization and stroke);

Secondary

MeasureTime frame
Complications (such as kidney injury, lower limb ischemia and bacteremia);Follow-up results of 1, 2 and 3 years after discharge (including all-cause death, acute myocardial infarction, revascularization and stroke);

Countries

China

Contacts

Public ContactBai Ming

The First Hospital of Lanzhou University

baiming@vip.163.com+86 13893220909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026